Abstract: Verification and validation of automated driving systems’ safety are some of the biggest challenges for the introduction of automated vehicles into the market. Scenario-based safety ...
Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest analysis on the stock here.
Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX stock is a Buy.
Abstract: Sample site selection is crucial for asteroid sample return missions, requiring a strategy that considers factors such as terrain and illumination for mission safety. However, the lack of ...
Objective: This study aimed to determine optimal sample sizes and the relationships between sample size and dataset-level characteristics over a variety of binary classification algorithms. Methods: A ...